Excelsior Biopharma (Taiwan) Analysis
| 6496 Stock | TWD 32.15 0.35 1.10% |
Excelsior Biopharma is fairly valued with Real Value of 31.88 and Hype Value of 32.15. The main objective of Excelsior Biopharma stock analysis is to determine its intrinsic value, which is an estimate of what Excelsior Biopharma is worth, separate from its market price. There are two main types of Excelsior Biopharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Excelsior Biopharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Excelsior Biopharma's stock to identify patterns and trends that may indicate its future price movements.
The Excelsior Biopharma stock is traded in Taiwan on Taiwan OTC Exchange, with the market opening at 09:00:00 and closing at 13:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Taiwan. Excelsior Biopharma is usually not traded on Adjusted Holiday / Chinese New Year 's Eve, Chinese New Year 's Eve, Chinese New Year, Dragon Boat Festival, National Day of the Republic of China, Chinese New Year 2, Chinese New Year 3, Adjusted Holiday 1, Adjusted Holiday 2, Mid - autumn / Moon Festival. Excelsior Stock trading window is adjusted to Asia/Taipei timezone.
Excelsior |
Excelsior Stock Analysis Notes
About 61.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.09. In the past many companies with similar price-to-book ratios have beat the market. Excelsior Biopharma recorded a loss per share of 0.63. The entity last dividend was issued on the 13th of July 2021. For more info on Excelsior Biopharma please contact the company at 886 2 2655 7568 or go to https://www.excelsiorgroup.com.tw.Excelsior Biopharma Investment Alerts
| The company reported the revenue of 1.34 B. Net Loss for the year was (15.65 M) with profit before overhead, payroll, taxes, and interest of 293.35 M. | |
| About 61.0% of the company shares are owned by insiders or employees |
Excelsior Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.32 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Excelsior Biopharma's market, we take the total number of its shares issued and multiply it by Excelsior Biopharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Excelsior Profitablity
Excelsior Biopharma's profitability indicators refer to fundamental financial ratios that showcase Excelsior Biopharma's ability to generate income relative to its revenue or operating costs. If, let's say, Excelsior Biopharma is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Excelsior Biopharma's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Excelsior Biopharma's profitability requires more research than a typical breakdown of Excelsior Biopharma's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.04) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.04. Technical Drivers
As of the 24th of January, Excelsior Biopharma shows the Mean Deviation of 1.6, downside deviation of 3.46, and Semi Deviation of 2.24. Excelsior Biopharma technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Excelsior Biopharma mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation to decide if Excelsior Biopharma is priced favorably, providing market reflects its regular price of 32.15 per share.Excelsior Biopharma Price Movement Analysis
The output start index for this execution was eleven with a total number of output elements of fifty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Excelsior Biopharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Excelsior Biopharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Excelsior Biopharma Outstanding Bonds
Excelsior Biopharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Excelsior Biopharma uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Excelsior bonds can be classified according to their maturity, which is the date when Excelsior Biopharma has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Excelsior Biopharma Predictive Daily Indicators
Excelsior Biopharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Excelsior Biopharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Excelsior Biopharma Forecast Models
Excelsior Biopharma's time-series forecasting models are one of many Excelsior Biopharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Excelsior Biopharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Excelsior Biopharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
Additional Tools for Excelsior Stock Analysis
When running Excelsior Biopharma's price analysis, check to measure Excelsior Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Excelsior Biopharma is operating at the current time. Most of Excelsior Biopharma's value examination focuses on studying past and present price action to predict the probability of Excelsior Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Excelsior Biopharma's price. Additionally, you may evaluate how the addition of Excelsior Biopharma to your portfolios can decrease your overall portfolio volatility.